Zura Bio Statistics
Total Valuation
Zura Bio has a market cap or net worth of $83.58 million. The enterprise value is -$107.26 million.
Important Dates
The next estimated earnings date is Wednesday, March 12, 2025, after market close.
Earnings Date | Mar 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Zura Bio has 65.29 million shares outstanding. The number of shares has increased by 199.50% in one year.
Current Share Class | 65.29M |
Shares Outstanding | 65.29M |
Shares Change (YoY) | +199.50% |
Shares Change (QoQ) | +16.53% |
Owned by Insiders (%) | 6.50% |
Owned by Institutions (%) | 49.23% |
Float | 37.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.53 |
P/TBV Ratio | 0.53 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.36
Current Ratio | 10.36 |
Quick Ratio | 10.32 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.85% and return on invested capital (ROIC) is -24.51%.
Return on Equity (ROE) | -36.85% |
Return on Assets (ROA) | -21.40% |
Return on Invested Capital (ROIC) | -24.51% |
Return on Capital Employed (ROCE) | -29.44% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.84M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.32% in the last 52 weeks. The beta is 0.06, so Zura Bio's price volatility has been lower than the market average.
Beta (5Y) | 0.06 |
52-Week Price Change | -63.32% |
50-Day Moving Average | 1.79 |
200-Day Moving Average | 3.33 |
Relative Strength Index (RSI) | 39.09 |
Average Volume (20 Days) | 266,178 |
Short Selling Information
The latest short interest is 5.13 million, so 7.85% of the outstanding shares have been sold short.
Short Interest | 5.13M |
Short Previous Month | 4.88M |
Short % of Shares Out | 7.85% |
Short % of Float | 13.75% |
Short Ratio (days to cover) | 5.43 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -50.28M |
Pretax Income | -58.52M |
Net Income | -42.62M |
EBITDA | n/a |
EBIT | -50.28M |
Earnings Per Share (EPS) | -$0.66 |
Full Income Statement Balance Sheet
The company has $188.22 million in cash and n/a in debt, giving a net cash position of $188.22 million or $2.88 per share.
Cash & Cash Equivalents | 188.22M |
Total Debt | n/a |
Net Cash | 188.22M |
Net Cash Per Share | $2.88 |
Equity (Book Value) | 170.83M |
Book Value Per Share | 2.34 |
Working Capital | 170.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$21.31 million and capital expenditures -$30,000, giving a free cash flow of -$21.34 million.
Operating Cash Flow | -21.31M |
Capital Expenditures | -30,000 |
Free Cash Flow | -21.34M |
FCF Per Share | -$0.33 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |